Centene stock holds firm as earnings and buying support it
Published on 08/28/2026 at 19:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Centene Corp. (US15133V1035) is trading near $65 after a quarterly EPS of $2.51 on revenue of $53.58 billion, while one institutional filing showed a 334,628-share purchase worth $21.48 million and a 0.07% stake. The stock also sits close to its 52-week high of $69.36 and above its 200-day moving average of $53.16 as of August 27, 2026.
Results still set the tone
The latest reported quarter, for the period ended June 30, 2026, showed revenue up 9.9% year over year and EPS ahead of the $1.09 consensus by $1.42. That is the kind of spread that keeps the debate centered on execution rather than valuation alone.
MarketBeat's latest report also put Centene's market cap at $32.22 billion, a 50-day moving average of $65.26 and a 12-month range of $28.24 to $69.36. The share price of $65.23 on August 27, 2026 was 1.84% above the start of the year level shown in the same market snapshot.
Analyst view remains mixed
The same report said analysts had a consensus rating of Hold and a consensus price target of $70.05, with current-year EPS expectations at 4.89. That leaves the stock less than $5 above the target and gives the latest quarter's beat a clearer context.
Recent trading has also been orderly: volume reached 3,647,686 shares in one session, below the 5,861,675-share average cited in the filing note. A close in the mid-$65 area leaves the stock between its 50-day and 200-day moving averages, which helps explain why the latest report matters more than a one-day move.
Medicaid and managed care
Centene is still defined by government-sponsored health plans, especially Medicaid, CHIP and Medicare Advantage, so every quarterly beat or miss feeds directly into margin expectations. The company said its quarterly net margin was negative 2.51%, even with return on equity at 12.12% in the same report.
Price level matters
Centene shares last traded at $65.33 on August 27, 2026, with a market cap of $32.27 billion and a year-to-date gain of 58.72%. The gap to the 52-week high of $69.36 is less than $4, so the next move is still being judged against that ceiling.
Centene Corp.
Company: Centene Corp.
ISIN: US15133V1035
Ticker: CNC
Exchange: NYSE
Sector / Industry: Health Care / Managed Health Care
Index membership: S&P 500
Market cap: $32.27 billion (as of August 27, 2026)
Price (as of August 27, 2026, 4:00 p.m. ET): $65.33 USD
Next earnings date: November 2026
More on Centene stock
The company's managed-care platform covers Medicaid, CHIP, Medicare Advantage and individual marketplace plans, which makes enrollment trends and reimbursement rates central to the earnings path.
